Status:
COMPLETED
Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
Lead Sponsor:
Aswan University Hospital
Conditions:
Alopecia Areata
Eligibility:
All Genders
14-40 years
Phase:
NA
Brief Summary
Alopecia Areata is a common condition. This study investigated the efficacy of calcipotriol versus Narrow Band Ultraviolet B in treatment of Alopecia areata and their effects on serum vitamin D3 level...
Eligibility Criteria
Inclusion
- Alopecia Areata of scalp
Exclusion
- Other causes of alopecias including scarring alopecia, androgenic alopecia, telogen effluvium autoimmune diseases, pregnant and lactating females
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03847441
Start Date
October 1 2017
End Date
December 31 2018
Last Update
April 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528